Qualitative evaluation of mobile cancer apps with particular attention to the target group, content, and advertising

Böhme, Cathleen; Osthoff, Marc Baron von; Frey, Katrin; Hübner, Jutta

doi:10.1007/s00432-017-2533-0

Cited by 31 publications

(32 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Of these, one paper was excluded as it was not relevant and a further five papers were removed as they were based on unpublished or unreleased apps (not available in online stores). This left 13 papers for inclusion in our final review [12][13][14][15][16][17][18][19][20][21][22][23][24] (Fig. 1).…”

Section: Study Selectionmentioning

confidence: 99%

“…The app group had significantly less burden in emotional functioning, insomnia, and urinary-related symptoms at the end of treatment and 3 months later than the control group Authors found that the app (which they developed) had a role in facilitating supportive care needs during cancer treatment Performed using non-randomised control trial This highlights the importance of early detection and management of symptoms (especially in anxiety and depression which can cause sleep disturbances), which can be facilitated by the use of the app Böhme et al [13] Evaluation of the quality and accuracy of mobile cancer apps…”

Section: Studies Related To 'App Readability'mentioning

confidence: 99%

“…Procee had the best rating for cultural sensitivity [19]. Bohme et al [13] evaluated the quality of apps, using the Mobile Application Rating Scale (MARS) and German Cancer Society (GCS) instruments to determine the quality of information contained within the apps for breast, prostate and colorectal cancer. The tools had 3 domains (engagement, aesthetics and information) and 22 aspects were evaluated.…”

Section: Studies Related To 'Quality and Accuracy Of Apps'mentioning

confidence: 99%

“…24 apps in the study were PCAs. Of all apps included in the study, around 48.78% were considered deficient or insufficient [13]. The authors reported the overall quality of apps which were targeted at patients were of better quality than those targeted at either healthcare professionals or the general population.…”

Section: Studies Related To 'Quality and Accuracy Of Apps'mentioning

confidence: 99%

“…The full analysis and breakdown of these apps and their content can be seen in Table 2. Additionally, one study reported deficient or insufficient quality for data protection for cancers apps [13]. The gross majority (36 of 43) of the PCAs haven't been updated in the last year and, therefore, there is doubt if the existing data in these apps is current.…”

Section: Individual Applications Includes Studies Evaluated By the Aumentioning

confidence: 99%

See 4 more Smart Citations

Do prostate cancer-related mobile phone apps have a role in contemporary prostate cancer management? A systematic review by EAU young academic urologists (YAU) urotechnology group

et al. 2020

View full text Add to dashboard Cite

Aims and objectives To review the available literature regarding the use of prostate cancer-related mobile phone applications (PCA). Materials and methods The search was for English language articles between inceptions of databases to June 2019. Medline, EMBASE, Cochrane Library, CINAHL and Web of Science were searched. Full-text articles were reviewed, and the following data were extracted to aid with app analysis: name of application, developer, platform (Apple App Store or Google Play Store) and factors assessed by the article. Results The search yielded 1825 results of which 13 studies were included in the final review. 44 PCAs were identified from the data collected of which 59% of the PCAs had an educational focus. 11 apps were inactive and 5 weren’t updated within the last year. Five studies focused on the development and testing of apps (MyHealthAvatar, CPC, Rotterdam, Interaktor, NED). Two studies evaluated the readability of PCAs. Most PCAs had a reading level greater than that of the average patient. Two studies evaluated the quality and accuracy of apps. Majority of PCAs were accurate with a wide range of information. The study reported most PCAs to have deficient or insufficient scores for data protection. Two studies evaluated the accuracy of Rotterdam, CORAL and CPC risk calculators. Rotterdam was the best performer. Conclusions PCAs are currently in its infancy and do require further development before widespread integration into existing clinical practise. There are concerns with data protection, high readability standards and lack of information update in current PCAs. If developed appropriately with responsible governance, they do have the potential to play important roles in modern-day prostate cancer management

show abstract

Section: Study Selectionmentioning

confidence: 99%

Section: Studies Related To 'App Readability'mentioning

confidence: 99%

Section: Studies Related To 'Quality and Accuracy Of Apps'mentioning

confidence: 99%

Section: Studies Related To 'Quality and Accuracy Of Apps'mentioning

confidence: 99%

Section: Individual Applications Includes Studies Evaluated By the Aumentioning

confidence: 99%

See 3 more Smart Citations

Do prostate cancer-related mobile phone apps have a role in contemporary prostate cancer management? A systematic review by EAU young academic urologists (YAU) urotechnology group

et al. 2020

View full text Add to dashboard Cite

show abstract

Perceptions of BELONG as a supportive e‐platform used by women with gynecologic cancers

et al. 2021

View full text Add to dashboard Cite

� The unmet needs of women with gynecologic cancers (GCs) can be readily addressed using high quality e-platforms � This pilot study documents women with GC perceptions of BELONG (https://belong.life/)-a cancer navigation and support Application (or App) connecting patients diagnosed with various types of cancers � Women (N = 25), with GCs (stages I to IV), used the App for 8 weeks and completed the user Mobile Application Rating Scale � Ratings of BELONG in domains of engagement, functionality, aesthetics, and information were high, with Ask an Oncologist, Ovarian Cancer Community, Clinical Trials, Treatment Information, and Support Resources representing the most frequently accessed topics � As e-platforms are developed at a rapid pace, users' input and evaluation of platform quality and utility should be prioritized

show abstract

Access to internet, smartphone usage, and acceptability of mobile health technology among cancer patients

Potdar

Thomas

DiMeglio

et al. 2020

Support Care Cancer

View full text Add to dashboard Cite

Purpose: The use of mobile health (mHealth) technologies to augment patient care, enables providers to communicate remotely with patients enhancing the quality of care and patient engagement. Few studies addressed barriers to its implementation, especially in medically underserved populations. Methods: A cross-sectional study of 151 cancer patients was conducted at an academic medical center in the United States. A trained interviewer performed structured interviews regarding the barriers and facilitators of patients' current and desired utilization of technology for healthcare services. Results: Of the 151 participants, 35.8% were male and ages ranged from 21-104 years. Only 73.5% of participants currently have daily access to internet, and 68.2% currently own a smartphone capable of displaying mobile applications. Among all participants, utilization of a daily mHealth application was signi cantly higher in patients with a college-level degree (OR; 2.78, p<0.01) and lower in older patients (OR; 0.05, p<0.01). Differences in utilization when adjusted for current smartphone use and daily access to internet were nonsigni cant. Among smartphone users, the desire to increase cancer knowledge was associated with a higher likelihood of utilizing a mHealth application (OR; 261.53, p<0.01). Conclusion: The study suggests the access to mobile technology is the predominant determinant of utilization. Healthcare organizations should consider these factors when launching patient engagement platforms.

show abstract

Qualitative evaluation of mobile cancer apps with particular attention to the target group, content, and advertising

Cited by 31 publications

References 6 publications

Do prostate cancer-related mobile phone apps have a role in contemporary prostate cancer management? A systematic review by EAU young academic urologists (YAU) urotechnology group

Do prostate cancer-related mobile phone apps have a role in contemporary prostate cancer management? A systematic review by EAU young academic urologists (YAU) urotechnology group

Perceptions of BELONG as a supportive e‐platform used by women with gynecologic cancers

Access to internet, smartphone usage, and acceptability of mobile health technology among cancer patients

Contact Info

Product

Resources

About